tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Alnylam Pharmaceuticals: Strong Long-Term Growth Strategy But Balanced Risk/Reward Supports Hold Rating
PremiumRatingsAlnylam Pharmaceuticals: Strong Long-Term Growth Strategy But Balanced Risk/Reward Supports Hold Rating
17d ago
Alnylam 2026 guidance reflects continued momentum, says H.C. Wainwright
Premium
The Fly
Alnylam 2026 guidance reflects continued momentum, says H.C. Wainwright
18d ago
Alnylam price target raised to $529 from $520 at Needham
Premium
The Fly
Alnylam price target raised to $529 from $520 at Needham
18d ago
Alnylam assumed with an Outperform at Oppenheimer
PremiumThe FlyAlnylam assumed with an Outperform at Oppenheimer
23d ago
Alnylam price target lowered to $491 from $525 at Bernstein
Premium
The Fly
Alnylam price target lowered to $491 from $525 at Bernstein
24d ago
Alnylam: Buy Rating Reaffirmed as Long-Term TTR Growth and Strategic Update Offset Near-Term Amvuttra Launch Concerns
Premium
Ratings
Alnylam: Buy Rating Reaffirmed as Long-Term TTR Growth and Strategic Update Offset Near-Term Amvuttra Launch Concerns
24d ago
BridgeBio price target raised to $86 from $75 at Leerink
PremiumThe FlyBridgeBio price target raised to $86 from $75 at Leerink
2M ago
Nasdaq-100 Reshuffle: Who’s In, Who’s Out?
Premium
Market News
Nasdaq-100 Reshuffle: Who’s In, Who’s Out?
2M ago
Nasdaq adding Alnylam, Ferrovial, Insmed, Monolithic Power at open on 12/22
Premium
The Fly
Nasdaq adding Alnylam, Ferrovial, Insmed, Monolithic Power at open on 12/22
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100